Efficiency And Quality In Post-Surgical Pain Therapy After Discharge
Key facts
- Who runs it
- University of Nebraska
- Where
- Omaha, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 711 people enrolled
- Started
- 2 May 2022
- Ended
- 10 Dec 2023
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Empowering Patient to Steer Their Pain Management After Surgery
- Provider-facing Prescription Aid
- Record updated
- 1 July 2025
Who can take part
- Age
- 19 years to 89 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- 19-89 years old
- Access to a smartphone (iOS or Android)
- Inpatient surgery requiring at least over-night hospitalization and anticipated discharge to home
Who cannot take part
- Long-term opioid therapy (AHRQ definition - opioid use on most days >3 months) prior to surgery
- Re-hospitalization within 30 days
- Pregnant
- Unable to read the English language
- Discharge to a post-acute care facility
- Contraindications to opioids, acetaminophen, or NSAIDs
Where in United States
- University of Nebraska Medical CenterOmaha, United States
About the trial
What the trial wants to find out
Following inpatient surgery, more than 80% of patients are prescribed opioids for use after discharge, yet up to 90% of patients report leftover opioids, and only 16% maximize non-opioid therapy. The proposed study seeks to test a provider-facing decision support tool and a participant-facing smartphone app to reduce the amount of opioids prescribed and taken following discharge, while ensuring effective treatment of pain after surgery. Adult participants with smart phones having had inpatient surgery requiring at least over-night hospitalization with anticipated discharge to home will be randomized to one of the two groups. Study measurements will include self-reported cumulative amounts of opioids taken after discharge, non-opioid analgesic taken, prescribed post-discharge opioid doses in morphine milligram equivalents (MME), pain intensity and pain interference scores (PROMIS), need for additional opioid prescriptions within one-month post-discharge, as well as any self-reported disposal of leftover medications.
The 4 groups in the trial
- UControlPain App With Only Data Collection Function (Control)No study treatment, for comparison
UControlPain App with only data collection function. No provider-facing prescription intervention.
- UControlPain Educational App OnlyExisting treatment, for comparison
UControlPain app with education components. No provider-facing prescription intervention.
Treatment: Empowering Patient to Steer Their Pain Management After Surgery
- UControlPain App and Provider Facing ToolExisting treatment, for comparison
UControlPain app with education components and provider-facing prescription intervention. Once half of the subjects are enrolled, the provider-facing tool will be turned on. Participants will be masked to when the provider-facing tool is activated.
Treatment: Empowering Patient to Steer Their Pain Management After Surgery and Provider-facing Prescription Aid
- Provider Facing Tool OnlyExisting treatment, for comparison
UControlPain App with only data collection function. Provider-facing prescription intervention. Once half of the subjects are enrolled, the provider-facing tool will be turned on. Participants will be masked to when the provider-facing tool is activated.
Treatment: Provider-facing Prescription Aid
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 1 July 2025